Symbol="ABEO"
AssetType="Common Stock"
Name="Abeona Therapeutics Inc"
Description="Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for rare, life-threatening genetic diseases. The company is headquartered in New York, New York."
CIK="318306"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1330 AVENUE OF THE AMERICAS, 33RD FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="108431000"
EBITDA="-42238000"
PERatio="None"
PEGRatio="0"
BookValue="0.435"
DividendPerShare="0"
DividendYield="0"
EPS="-1.85"
RevenuePerShareTTM="0.261"
ProfitMargin="0"
OperatingMarginTTM="-12.62"
ReturnOnAssetsTTM="-0.573"
ReturnOnEquityTTM="-2.672"
RevenueTTM="3568000"
GrossProfitTTM="-28001000"
DilutedEPSTTM="-1.85"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="2.5"
AnalystTargetPrice="21"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.71"
PriceToBookRatio="3.31"
EVToRevenue="9.47"
EVToEBITDA="-0.515"
Beta="1.346"
num_52WeekHigh="5.8"
num_52WeekLow="2.19"
num_50DayMovingAverage="3.825"
num_200DayMovingAverage="3.239"
SharesOutstanding="24755900"
DividendDate="None"
ExDividendDate="None"
symbol="ABEO"
open="4.11"
high="4.50"
low="4.08"
price="4.34"
volume="181987.00"
latest_trading_day="2023-08-30"
previous_close="4.11"
change="0.23"
change_percent="5.5961%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="17"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="83"
Volume_recent_avg="155697"
Change_recent_avg="0.01"
Delta_recent_avg="0.27"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="0.12"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="83"
Aroon_momentum_negative="17"
image_negative_thumbnail_id_1="169"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0007.jpeg"
image_negative_thumbnail_id_2="1101"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0134.jpeg"
image_neutral_thumbnail_id_1="522"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0077.jpeg"
image_neutral_thumbnail_id_2="581"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_positive_thumbnail_id_1="669"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0039.jpeg"
image_positive_thumbnail_id_2="988"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0150.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
